These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


482 related items for PubMed ID: 26634305

  • 21. Between-assay variability of faecal calprotectin enzyme-linked immunosorbent assay kits.
    Whitehead SJ, French J, Brookes MJ, Ford C, Gama R.
    Ann Clin Biochem; 2013 Jan; 50(Pt 1):53-61. PubMed ID: 23129721
    [Abstract] [Full Text] [Related]

  • 22. Rapid faecal tests for detecting disease activity in colonic inflammatory bowel disease.
    Puolanne AM, Kolho KL, Alfthan H, Ristimäki A, Mustonen H, Färkkilä M.
    Eur J Clin Invest; 2016 Oct; 46(10):825-32. PubMed ID: 27438629
    [Abstract] [Full Text] [Related]

  • 23. The prognostic significance of faecal calprotectin in patients with inactive inflammatory bowel disease.
    Zhulina Y, Cao Y, Amcoff K, Carlson M, Tysk C, Halfvarson J.
    Aliment Pharmacol Ther; 2016 Sep; 44(5):495-504. PubMed ID: 27402063
    [Abstract] [Full Text] [Related]

  • 24. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
    Mirsepasi-Lauridsen HC, Bachmann Holmetoft U, Ingdam Halkjær S, Angeliki Krogfelt K, Munk Petersen A.
    Scand J Gastroenterol; 2016 Sep; 51(2):211-7. PubMed ID: 26359672
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Within-Stool and Within-Day Sample Variability of Fecal Calprotectin in Patients With Inflammatory Bowel Disease: A Prospective Observational Study.
    Du L, Foshaug R, Huang VW, Kroeker KI, Dieleman LA, Halloran BP, Wong K, Fedorak RN.
    J Clin Gastroenterol; 2018 Mar; 52(3):235-240. PubMed ID: 28009684
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
    Kotze LM, Nisihara RM, Marion SB, Cavassani MF, Kotze PG.
    Arq Gastroenterol; 2015 Mar; 52(1):50-4. PubMed ID: 26017083
    [Abstract] [Full Text] [Related]

  • 33. Comparison of the Liaison® Calprotectin kit with a well established point of care test (Quantum Blue - Bühlmann-Alere®) in terms of analytical performances and ability to detect relapses amongst a Crohn population in follow-up.
    Delefortrie Q, Schatt P, Grimmelprez A, Gohy P, Deltour D, Collard G, Vankerkhoven P.
    Clin Biochem; 2016 Feb; 49(3):268-73. PubMed ID: 26506117
    [Abstract] [Full Text] [Related]

  • 34. Faecal calprotectin: a new marker for Crohn's disease?
    Wassell J, Dolwani S, Metzner M, Losty H, Hawthorne A.
    Ann Clin Biochem; 2004 May; 41(Pt 3):230-2. PubMed ID: 15117438
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 25.